Jury finds Fosamax caused dead jaw

The second trial over the drug Fosamax resulted in a verdict of $8 million dollars for Shirely Boles. Mrs. Boles, 71, sued Merck for jaw damage (dead jaw) resulting from her use of the osteoporosis drug Fosamax for 9 years.

Merck’s Fosamax (drug: Alendronate) is used to treat two bone disorders, osteoporosis in postmenopausal women and Paget’s disease. Osteoporosis causes a decrease in bone mass volume and reduction in bone strength leading to fracture of spine, wrist and hip. In Paget’s disease, healthy bone is deteriorated to poor quality bone resulting in many bone disorders.  Fosamax was the first of a class of drugs called bisphosphonates which gave women an alternative to traditional treatments for osteoporosis (estrogen (female sex hormone) and calcitonin).

The lawsuits claim that Fosamax causes osteonecrosis of the jaw.  Osteonecrosis is death of jawbone tissue due to poor blood supply to the jaw area. As on March 31 2010, close to 1,039 including approximately 1,417 plaintiff groups had been filed and were pending against Merck in either state or federal courts.

Merck states that they are responsible for the patient safety and hence enough patient safety data was collected from clinical trials and post marketing trials of Fosamax. These updates, Merck argued, were regularly provided to medical, scientific and regulatory communities and also sent to consumers.

Mrs. Boles’ alleged that she suffered from dead jaw and complications following two tooth extractions in June 2002. She was admitted to the hospital to treat her Fosamax related osteonecrosis.  Her treating doctor testified that Boles was unable to eat food and was “wasting away”. Doctors also indicated that she cannot orally consume the food and hence she will have to perform a surgery to remove a large section of her dead jaw bone and reconstruct her face.  Mrs. Boles’ used Fosamax from 1997 to 2006.

Merck has indicated that the company would appeal the jury’s decision as the compensation for damages were excessive and unjustified.



No comments yet.

Leave a Reply

GET HELP NOW!
  • This field is for validation purposes and should be left unchanged.
Latest Drug Injury News

Heightened Thrombosis Risk with Birth Control Patch and Ring

A BMJ study has found more evidence that women using the transdermal contraceptive patch or vaginal ring do indeed face higher thrombosis risks than those taking their contraceptive orally. Using Danish national registries, researchers studied over 1.5 million women without prior thrombotic disease or cancer, who were not pregnant. Overall, the incidence of venous thrombosis [...]

Is Your Heartburn Medication Putting You At Risk?

According to a new study, your heartburn medication could be putting you at risk for a nasty stomach bug! The infection, Clostridium difficile infection, also called C. difficile or CDI, is a hard-to-cure infection that causes severe diarrhea that has recently been linked to proton pump inhibitors (PPIs), the most powerful class of antacid drugs. [...]

Cipralex and Abnormal Heart Rhythms

Health Canada is informing Canadians of a labeling update for the prescription drug Cipralex (Escitalopram) regarding a dose-related risk of abnormal heart rhythms. The risk is dose-related, 20 mg per day is still the maximum recommended dose for most patients. Before starting Cipralex, talk to your healthcare professional. If you have had any heart problems, what other medications you [...]

Florida Compounding Pharmacy Linked To Rare Fungal Eye Infections

Whats that in my eye?! Thirty-three cases of a rare, but serious, fungal eye infection have been confirmed across seven states. Federal officials are announcing that the infection stemmed from products mixed in a Florida compounding pharmacy. it seems the victims underwent some sort of an eye procedure, either a surgery or injections. Of these, [...]

Multaq and Death By Heart Problems

Multaq, also known as Dronedarone, is used to treat heart patients that had atrial fibrillation, which is a rhythm disorder that could make the heart beat fast and irregular. It’s also used to treat atrial flutter, which also causes the heart to beat fast, but is still considered regular. However, this drug is known to [...]

Latest Medical Device Injury News

More Sufferers File Lawsuits Against DePuy Orthopaedics

Two more people who’ve suffered serious injuries blamed on the defective and recalled DePuy Orthopaedics ASR hip implant are the latest to join a growing federal class-action lawsuit against the medical device firm and its parent company, Johnson & Johnson. The plaintiff’s are being represented by the law firm of Parker Waichman LLP and are [...]

Metal-on-Metal Hip Implant Finds No Increased Cancer Risk?

We have written countless articles discussing the dangers of metal-on-metal implants, yet a new study is downplaying the potential dangerous effects, such as the risk of cancer. The recent study was published in the British Medical Journal which analyzed cancer rates among patients with metal-on-metal implants versus patients with other types of implants as well [...]

St. Jude’s Wants Study Retracted Due To Inaccuracy

St. Jude Medical has asked the Heart Rhythm Journal to retract a study published last month that linked its Riata line of internal defibrillator leads to more 20 deaths. In a statement issued by St. Jude, the company asserted the Riata lead study was biased and based on inaccurate facts. According to the Heart Rhythm [...]

Vaginal Mesh Lawsuits Claim Painful Erosion, Organ Damage

An estimated 35,000 women who suffered through bladder control problems brought on by aging, child birth, and a variety of other causes. The lives of those who had adverse reactions to vaginal mesh were literally ruined as many experienced crippling pain and permanent scarring damage from the procedures involved in the insertion and necessary removal of the vaginal mesh.

If you or a loved one suffered vaginal erosion call us immediately at 1-800-810-3457.

FDA Reposts Thoratec HeartMate II LVAS Class I Recall

A recall of Thoratec’s HeartMate II Left Ventricle Assist System (LVAS) that was first announced in February has been designated Class I, the U.S. Food & Drug Administration’s (FDA) most serious type of recall. The HeartMate II LVAS is a heart pump which is used as a bridge to transplantation in heart transplant candidates at [...]